Beovu
12.15.20
Novartis Reports Positive Topline Results From Second Phase 3 Trial of Beovu in Patients With DMESource: Novartis
10.05.20
Beovu Now Available in Canada, Receives Positive Reimbursement RecommendationSource: Novartis
09.15.20
European Medicines Agency (EMA) Approves Safety Label Update for Novartis’ BeovuSource: Novartis
07.27.20
New Novartis Analysis Examines Sustainable Fluid Control of Beovu Compared With AfliberceptSource: Novartis
03.02.20
Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMDSource: Novartis
02.25.20
Novartis Responds to ASRS Note Raising Safety Concerns With Wet AMD Drug BeovuSource: Eyewire News